-+ 0.00%
-+ 0.00%
-+ 0.00%

Rapport Therapeutics Reports Strong Phase 2a Results for RAP-219 in Drug-Resistant Focal Onset Seizures

路透·12/05/2025 14:00:37

登录查看新闻详情